Member Info for Sharedealer2019

Just wondering buckstead, who is the top and who is the bottom out of you and Andy?

Synairgen are going no where as their treatment will be around for years to come!

https://coronavirus.data.gov.uk/
Yesterdays numbers

Doc83 all I can imagine is you have never been a director of a company, we have rules and regulations we have to abide by. All RNS's will be seen and reviewd by the CEO and most likely 'A another board member' before they are published and ANYONE who thinks differerntly deserves their place in the funny farm.

Doc83....did you see him while you were checking in?

Doc83....he is alive and well and on the 17th of March...only yesterday made a lovely comment! So your mind can rest assured he is live and kicking and ready to come out fighting when the correct results are ready to be published! :)
Happy to have given you the good news he is doing well!

Sorry Mrcosts I fell asleep after your first sentance, you were saying something about RM not posting....and I corrected you, so you were wrong, ok, thanks for the clarification....
Ill just post this again for you...
'Richard Marsden, CEO of Synairgen, commented: "...and are working closely with the NIH to also find a suitable trial for SNG001 in home-based patients."'

And for those people who are going to be very very excited when the data comes out.
As Gunto said....'Tesco are doing an offer on Andrex.'

Seems we are thinking along the same lines then :)

Was that meant for me Gunto ;)?

@Mrcosts your point was he had not said anything for ages...I was pointing out that as someone who is also heavily invested in this company I fully read the RNS and noticed a rather lovely written part that showed RM had commented, saying radio silence is incorrect.
Let me post what he said again as I think the more people read it the more they will find positives as I did!

'Richard Marsden, CEO of Synairgen, commented: "Conducting clinical trials in the time of COVID-19 is challenging but as important now as at the start of the pandemic. Even with improved standard of care, there remains a critical need to prevent progression to severe disease and death. As such, we are actively seeking inclusion in platform trials for hospitalised patients and are working closely with the NIH to also find a suitable trial for SNG001 in home-based patients."'

This is the part of what RM said that I really liked...
'and are working closely with the NIH to also find a suitable trial for SNG001 in home-based patients'

Worth reading the RNS to full digest as it seems some just glaced over it.

Mrcosts.....

17th of March, just yesterday
'Richard Marsden, CEO of Synairgen, commented: "Conducting clinical trials in the time of COVID-19 is challenging but as important now as at the start of the pandemic. Even with improved standard of care, there remains a critical need to prevent progression to severe disease and death. As such, we are actively seeking inclusion in platform trials for hospitalised patients and are working closely with the NIH to also find a suitable trial for SNG001 in home-based patients."'

Not quite radio silence, may not have been what we wanted, but not radio silence.

Expecting to see Polygon RNS on Tuesday based on their previous buying patterns, not sure they would have crossed the threshold today but would expect them to have by close of play tomorrow.

If it’s that bad why can’t I get an order to buy currently….NT to buy £250

Agree Jonny, can see positives in this RNS, maybe not the quick win everyone wanted but still a good long term hold

Burstead…. Will be holding as I STILL see the benefit to the drug on Covid, COPD, Asthma and many other viruses yet to be found. So yes more than happy to hold thanks! :)

Mr costs no one cares what you think! Bahhh humbug!!

Am now expecting another price monitoring RNS tonight

Just changed....now received an offer!
However....if we are 9% down.....and I would imagine plenty of shares available, then why NT to buy, same thing happened yesterday too.